Steven Cohen’s TG Therapeutics TGTX Stock Holding History

Steven Cohen’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.6M	Buy	+264,963	New	+$10.8M	0.02%	1059
2026 Q1	–	Sell	-231,358	Closed	-$6.9M	–	4495
2025 Q4	$6.9M	Sell	231,358 -134,474	-37%	-$4.39M	0.01%	1588
2025 Q3	$13.2M	Sell	365,832 -351,678	-49%	-$11.6M	0.02%	696
2025 Q2	$25.8M	Buy	+717,510	New	+$26.7M	0.05%	417
2024 Q3	–	Sell	-585,873	Closed	-$12.8M	–	2341
2024 Q2	$10.4M	Buy	+585,873	New	+$9.35M	0.03%	604
2023 Q4	–	Sell	-611,678	Closed	-$5.11M	–	2814
2023 Q3	$5.11M	Buy	611,678 +293,408	+92%	+$4.09M	0.01%	874
2023 Q2	$7.91M	Buy	318,270 +297,589	+1,439%	+$7.69M	0.02%	662
2023 Q1	$311K	Buy	+20,681	New	+$314K	﹤0.01%	1349
2022 Q4	–	Sell	-437,200	Closed	-$2.59M	–	1788
2022 Q3	$2.59M	Buy	+437,200	New	+$2.87M	0.01%	873
2019 Q4	–	Sell	-19,845	Closed	-$111K	–	1245
2019 Q3	$111K	Sell	19,845 -680,155	-97%	-$4.74M	﹤0.01%	977
2019 Q2	$6.05M	Sell	700,000 -578,900	-45%	-$4.38M	0.03%	472
2019 Q1	$10.3M	Buy	+1,278,900	New	+$6.91M	0.05%	392
2018 Q2	–	Sell	-603,800	Closed	-$8.57M	–	1179
2018 Q1	$8.57M	Buy	+603,800	New	+$7.72M	0.04%	460

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Steven Cohen's TGTX Position: Q2 2026 in Review

Steven Cohen opened a new position in TG Therapeutics (TGTX) in Q2 2026: 264,963 shares worth $14.6M. The stake represents 0.02% of the portfolio and ranks #1059 among its holdings. This is a return to the name: Steven Cohen previously reported a position in TGTX as recently as Q4 2025.

Steven Cohen first reported a position in TGTX in Q1 2018 and has held it in 13 quarters since. The position peaked at $25.8M in Q2 2025. 426 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Steven Cohen held 264,963 shares of TG Therapeutics worth $14.6M as of Q2 2026.
TG Therapeutics was a new Steven Cohen position in Q2 2026.
TG Therapeutics made up 0.02% of Steven Cohen's portfolio in Q2 2026, its #1059 holding.
Steven Cohen first reported a position in TG Therapeutics in Q1 2018 and has held it in 13 quarters since.
Steven Cohen's TG Therapeutics position peaked at $25.8M in Q2 2025.
426 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.